Revista de la Sociedad Argentina de Diabetes (Sep 2020)

Table 2: Heart failure and diabetes mellitus type 2

  • Julieta Méndez,
  • Carolina Gómez Martín,
  • Javier Remón,
  • Solange Houssay,
  • Ezequiel Forte,
  • Silvana Manfredo,
  • María Laura Roselli,
  • Matías Re,
  • Débora Hernández,
  • Marina Margosian,
  • Melina Sabán,
  • Martín Maraschio,
  • Natalia Blanco,
  • Rubén de Marco,
  • Sandra Salva

DOI
https://doi.org/10.47196/diab.v54i2Sup.252
Journal volume & issue
Vol. 54, no. 2Sup
pp. 91 – 106

Abstract

Read online

Since the Framingham study in 1974 reported a 2 to 5 fold increase in the risk of developing heart failure (HF) in patients with diabetes mellitus (DM), other observational studies confirmed this association that has gained great visibility in recent years from of the results of cardiovascular safety studies of antidiabetic drugs. HF is defined as a clinical syndrome that results from functional or structural deterioration of ventricular filling or blood ejection. It can be classified according to the ejection fraction, the presence of symptoms and the limitation to physical activity. There are different factors associated with HF in people with DM such as age, duration of the disease, insulin use, coronary heart disease, high blood pressure, peripheral arterial disease, increased creatinine, poor glycemic control, albuminuria and obesity. In turn, HF is associated with insulin resistance and dysglycemic states that are considered of risk for the development of DM.

Keywords